Key points from article :
Biotech company Epirium is pursuing that holy grail of medical research.
They scored the largest fundraising in 2019, surpassed $50 million series B of Life Biosciences.
Drug candidate to initially be tested to treat Becker muscular dystrophy.
“There’s no question we will evolve.” [to benefit one disease to larger ones].
Claims to have discovered a "novel pharmacological approach' to treat diseases.
Diseases that are caused by mitochondrial depletion and dysfunction.
Proof-of-concept human studies has been carried out and plans for 2020 trials.
